Journal
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
Volume 23, Issue 3, Pages 625-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2009.04.008
Keywords
Critical illness; ICU; Fungal infection; Candida; Aspergillus; Invasive
Categories
Ask authors/readers for more resources
Pulmonologists and intensivists often care for patients at risk for infections caused by both Aspergillus and Candida. Infection with either can lead to severe life-threatening disease, particularly in immunosuppressed patients, with mortality rates for invasive fungal disease often exceeding 30%. For both organisms, multiple diagnostic challenges remain while newer diagnostic modalities are being developed and tested. Fortunately, therapeutic paradigms are shifting, and clinicians have many new agents in their armamentarium for combating fungal infection. Given the rapidly changing literature in this broad area, it is imperative that physicians caring for immunosuppressed patients and for the critically ill remain abreast of this evolving field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available